Portal Hypertension and Other Complications of Cirrhosis: Experimental and Translational

Nov 10 2025
Convention Center: Room 202, Level 2
5:00 PM - 6:30 PM

World Class Speakers

Yasuko Iwakiri, PhD, FAASLD
Abstract Presenter

Yasuko Iwakiri, PhD, FAASLD

Yale University
Justin Boike, MD, MPH
Abstract Presenter

Justin Boike, MD, MPH

Northwestern Memorial Hospital/Northwestern University
Yasuko Iwakiri, PhD, FAASLD
Moderator

Yasuko Iwakiri, PhD, FAASLD

Yale University
Justin Boike, MD, MPH
Moderator

Justin Boike, MD, MPH

Northwestern Memorial Hospital/Northwestern University

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Presentations

5:00 PM - 5:15 PM
May 19 2026
Washington, D.C.

CXCR3+ monocyte-derived macrophages contribute to congestive portal hypertension through the glycolysis-dependent synthesis of vasoactive molecules: insights from multiomics

Yasuko Iwakiri, PhD, FAASLD , Abstract Presenter
Cirrhosis and Portal Hypertension
5:15 PM - 5:30 PM
May 19 2026
Washington, D.C.

Pressure‑induced endothelial fibulin‑7 modulates HSC phenotype and lowers portal pressure in experimental cirrhosis

Justin Boike, MD, MPH , Abstract Presenter
Cirrhosis and Portal Hypertension

Objectives

  • Describe recent experimental and translational discoveries related to complications of cirrhosis, including portal hypertension and hepatic encephalopathy.